Last reviewed · How we verify
Fluor varnish
At a glance
| Generic name | Fluor varnish |
|---|---|
| Also known as | Fluor dental varnish |
| Sponsor | Universidad Autonoma de San Luis Potosí |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Effects of Different Remineralization Agents on Molar Incisor Hypomineralization Defects: a Randomized Clinical Study (NA)
- Randomized Clinical Trial: Oral Health Package Law and Fluor Varnish Impact on Schoolchildren in Merida, Mexico (PHASE3)
- Preventive Therapy of White Spot Lesions Using Different Remineralizing Agents in Children From 3 to 12 Years Old (NA)
- Streptococcus Mutans Reduction Early Mother-infant Transmission (PHASE4)
- Assessment of Inhibition of Biofilm Formation and Plaque Bacterial Count of Fluoride Varnish Containing Chlorhexidine and Cetylpyridinium Chloride Versus Conventional Fluoride Varnish (PHASE4)
- Clinical Effectiveness of Various Professionally Applied Fluoride Prophylaxes in Groups at High Risk (NA)
- Efficacy of Fluor Protector S in the Prevention in Adolescents (NA)
- Preventive Treatment Approach of Early Caries Lesions With Contemporary Methods of Remineralization (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fluor varnish CI brief — competitive landscape report
- Fluor varnish updates RSS · CI watch RSS
- Universidad Autonoma de San Luis Potosí portfolio CI